United States · FDA National Drug Code directory
Lansoprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-571_03b7dceb-2128-4324-b068-7f76a2d9887e
- Product NDC
- 31722-571
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Lansoprazole
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200518
- Source listing expiry
- 20261231
Source-listed ingredients
- LANSOPRAZOLE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-571-01) · 31722-571-01
- 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-571-05) · 31722-571-05
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-571-10) · 31722-571-10
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-571-30) · 31722-571-30
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (31722-571-90) · 31722-571-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →